Overview
- Due to new insights, it is now becoming possible to apply the discoveries in the field of apoptosis (programmed cell death) to treating cancer patients.
- This book presents an update of the most recent developments in this explosive field
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (15 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients.
Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the world’s leading experts in these fields.
Authors and Affiliations
Bibliographic Information
Book Title: Application of Apoptosis to Cancer Treatment
Authors: Mels Sluyser
DOI: https://doi.org/10.1007/1-4020-3302-8
Publisher: Springer Dordrecht
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Science+Business Media B.V. 2005
Hardcover ISBN: 978-1-4020-3303-2Published: 14 April 2005
Softcover ISBN: 978-90-481-6833-0Published: 19 October 2010
eBook ISBN: 978-1-4020-3302-5Published: 14 July 2005
Edition Number: 1
Number of Pages: VIII, 370
Topics: Cancer Research, Biomedicine general, Molecular Medicine, Pharmacology/Toxicology, Pharmacy, Life Sciences, general